ArticleSensors (Basel, Switzerland)2025
Machine Learning-Driven E-Nose-Based Diabetes Detection: Sensor Selection and Feature Reduction Study.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes is a major global health problem, with a rapidly increasing prevalence and long-term health complications in both developed and developing countries. If not diagnosed early, it can lead to cardiovascular diseases, kidney failure, vision loss, and nervous system disorders. This study aimed to classify individuals with diabetes or healthy individuals using e-nose sensor data obtained from breath samples taken from 1000 individuals. Six sensor features and one class feature were used in the analysis. Machine learning methods included Artificial Neural Networks (ANN), Decision Trees (DT), Gradient Boosting (GB), Naive Bayes (NB), and AdaBoost (AB). ANOVA and Information Gain analyses were conducted to determine the effectiveness of the sensor data, and the TGS2610 and TGS2611 sensors were found to be critical for classification. Principal Component Analysis (PCA) reduced data size and saved processing time. Experimental results showed that the ANN model provided the most successful classification, with 100% accuracy. AB and GB achieved 99.8% accuracy, while NB achieved 97.6% accuracy. Dimensionality reduction using PCA optimized training and testing times without loss of accuracy. The study presents a data-driven approach to e-nose-based diabetes detection, demonstrates the comparative performance of the models, and highlights the importance of sensor selection and data size optimization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.